Position in ANNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,720,180
+$1,698,745 QoQ
Shares Held
1,352,046
+24.4% QoQ
Ownership
0.661%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 216 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. ANNX ranks #130 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ANNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,720,180 | 1,352,046 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $6,021,435 | 1,086,902 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,975,839 | 792,000 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,402,508 | 787,708 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,783,737 | 743,224 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,980,032 | 1,025,925 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,282,615 | 1,029,750 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,677,184 | 790,065 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,720,944 | 555,295 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,983,407 | 555,566 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,667,427 | 367,275 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $852,518 | 361,237 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,334,783 | 379,200 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $310,728 | 80,709 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $417,916 | 80,835 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $500,400 | 80,971 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $207,473 | 55,033 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $744,188 | 272,597 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,380,195 | 294,186 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,339,841 | 286,934 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,615,867 | 293,908 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,164,900 | 257,360 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,455,864 | 178,021 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $5,187,044 | 171,586 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||